No abstract available
Keywords:
PD-1 inhibitor; immune-related adverse event; lymphoma; pembrolizumab; pneumonitis.
Publication types
-
Letter
-
Research Support, N.I.H., Extramural
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Aged
-
Antibodies, Monoclonal, Humanized / adverse effects*
-
Antineoplastic Agents, Immunological / adverse effects*
-
Female
-
Humans
-
Lymphoma / drug therapy*
-
Male
-
Middle Aged
-
Pneumonia / chemically induced*
-
Pneumonia / drug therapy
Substances
-
Adrenal Cortex Hormones
-
Antibodies, Monoclonal, Humanized
-
Antineoplastic Agents, Immunological
-
pembrolizumab